A Study of Jaktinib for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease.
Clinical trial NCT04971551 · UNKNOWN
Trial details
- NCT number
- NCT04971551
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-01
- Primary completion
- 2025-06-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.